Prosecution Insights
Last updated: November 04, 2026

Forsight Vision4 Inc.

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

Forsight Vision4 Inc. is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions are being reviewed by 2 distinct examiners, which ensures that each application is being evaluated independently. The prosecution is further divided across 2 distinct art units, indicating that the company's intellectual property spans different specialized areas within the biotechnology sector.

HAEJIN S PARK is the busiest examiner for this entity, currently overseeing 1 pending office action. Since there are 2 pending office actions and 2 distinct examiners, the workload is evenly split, with each examiner handling exactly one case. The involvement of 2 distinct art units for only 2 pending actions suggests that the company's current filings are technically diverse enough to require review by different administrative departments.

Practitioners should be aware that with 2 distinct examiners and 2 distinct art units, there is no overlap in the personnel or the departments reviewing the 2 pending office actions. This requires a tailored approach for each application, as the tendencies of HAEJIN S PARK in one art unit may not be applicable to the other examiner in a different art unit. The current state of 1 pending action per examiner represents a balanced but fragmented prosecution environment.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (67%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
Double-patenting only1 (33%)
Double-patenting + other1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEVY, BRANDON WILLIAM 1 62.9% +46.3%
PARK, HAEJIN S 1 55.1% +38.3%
TRUONG, QUANGLONG N 1 78.6% +23.3%

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18187898 POSTERIOR SEGMENT DRUG DELIVERY PARK, HAEJIN S 71d overdue
17864120 FLUID EXCHANGE APPARATUS FOR EXPANDABLE PORT DELIVERY SYSTEM AND METHODS OF USE TRUONG, QUANGLONG N 14d
18823545 IMPLANTABLE OCULAR DRUG DELIVERY DEVICES LEVY, BRANDON WILLIAM —

Top Art Units

Art UnitApps
3781 1
1614 1
1615 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18823545 IMPLANTABLE OCULAR DRUG DELIVERY DEVICES LEVY, BRANDON WILLIAM 3781 §103Other Final Rejection — Pending Sep 03, 2024
18187898 POSTERIOR SEGMENT DRUG DELIVERY PARK, HAEJIN S 1614 §112DP Final Rejection 71d overdue Pending Mar 22, 2023
17864120 FLUID EXCHANGE APPARATUS FOR EXPANDABLE PORT DELIVERY SYSTEM AND METHODS OF USE TRUONG, QUANGLONG N 1615 DP Non-Final OA 14d Pending Jul 13, 2022

Managing Forsight Vision4 Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Forsight Vision4 Inc. have?

Forsight Vision4 Inc. has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Forsight Vision4 Inc. applications?

Brandon William Levy has the most, with 1 of Forsight Vision4 Inc.'s pending office actions.

What technology area are Forsight Vision4 Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month